These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4289285)

  • 1. Urine steroid excretion in postmenopausal cancer of the breast. Response to corticotropin stimulation and dexamethasone suppression.
    Schweppe JS; Jungman RA; Lewin I
    Cancer; 1967 Jan; 20(1):155-63. PubMed ID: 4289285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Excretion of urinary steroids before and after administration of beta 1-24 corticotropin in patients with cancer of the breast].
    Tsyrlina E; Chemama R; Ennuyer A; Jayle MF
    Pathol Biol (Paris); 1970; 18(11):669-72. PubMed ID: 4317123
    [No Abstract]   [Full Text] [Related]  

  • 3. [FSH and steroid hormone excretion in breast cancer during chemotherapy].
    Sokolova VD; Sharoukhova KS; Goncharova MG; Murav'eva NI; Smirnova KD
    Vopr Onkol; 1972; 18(10):19-22. PubMed ID: 4197020
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gas-chromatographic studies of the behavior of urinary 17-ketosteroids, pregnanediol and pregnanetriol before and after stimulation with ACTH and after dexamethasone-induced depression and stimulation with LH (Jayle test) in normal subjects].
    Iacono G; D'Alessandro B; Gasbarro R; Bellastella A; Esposito V
    Boll Soc Ital Biol Sper; 1967 Sep; 43(18):1125-7. PubMed ID: 4294495
    [No Abstract]   [Full Text] [Related]  

  • 5. The excretion of pituitary gonadotrophins, oestrogens, pregnanediol and neutral 17-ketosteroids in the urine of patients with metastatic and recurrent mammary carcinoma.
    BROWN JB; BRUCE J; DOUGLAS M; KLOPPER A; LORAINE JA; STRONG JA
    Acta Endocrinol Suppl (Copenh); 1957; 24(Suppl 31):273-4. PubMed ID: 13443787
    [No Abstract]   [Full Text] [Related]  

  • 6. [Examination of the luteotropic hormone activity of blood and urinary steroid excretion in diseases of the breast].
    Márton Z; Gáti I; Doszpod J; Preisz J; Kecskés L
    Arch Geschwulstforsch; 1969; 34(2):179-87. PubMed ID: 5407886
    [No Abstract]   [Full Text] [Related]  

  • 7. [Some observations on the determination of urinary 17-ketosteroids in various climacteric conditions].
    Morresi G; Tomarchio C; Curiel P
    Riv Ostet Ginecol; 1967 Feb; 22(2):127-39. PubMed ID: 4300818
    [No Abstract]   [Full Text] [Related]  

  • 8. Ovarian lipoid cell tumor: urinary steroid response to adrenocorticotropin and chorionic gonadotropin.
    Morrow LB; Thompson RJ; Mellinger RC
    J Clin Endocrinol Metab; 1968 Dec; 28(12):1756-62. PubMed ID: 4301761
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and steroid metabolic studies in four siblings with congenital virilizing adrenal hyperplasia.
    Hall K; Hökfelt B
    Acta Endocrinol (Copenh); 1966 Aug; 52(4):535-49. PubMed ID: 4287879
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of orchidectomy on the excretion of testosterone, 17-ketosteroids, estrogens, pregnanediol, 17-hydroxycorticosteroids and gonadotropins in urine].
    Klosterhalfen H; Voigt KD; Tamm J
    Urol Int; 1965; 20(6):364-75. PubMed ID: 5873139
    [No Abstract]   [Full Text] [Related]  

  • 11. Urinary excretion of hormones during the climacteric.
    Furuhjelm M
    Acta Obstet Gynecol Scand; 1966; 45(3):352-64. PubMed ID: 5922482
    [No Abstract]   [Full Text] [Related]  

  • 12. The breast cancer discriminant: effect of age, obesity, hirsutism, starvation, and changes in adrenocortical and gonadal activity.
    Metcalf MG
    J Endocrinol; 1974 Nov; 63(2):263-74. PubMed ID: 4374483
    [No Abstract]   [Full Text] [Related]  

  • 13. Maternal urinary estriol excretion after dehydroepiandrosterone-sulfate infusion and adrenal stimulation and suppression.
    Scommegna A; Nedoss BR; Chattoraj SC
    Obstet Gynecol; 1968 Apr; 31(4):526-33. PubMed ID: 4296111
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of steroid homeostasis in the pathogenesis of cancer of the uterine cervix].
    Cherniavskaia GIa; Il'ubskaia EG; Tiutiunova AM; Nerodo GA; Rozenko LIa
    Vopr Onkol; 1982; 28(9):91-4. PubMed ID: 7123889
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of the hormonal activity of the corpus luteum after adrenal suppression during early pregnancy.
    Krawczuk A; Szamatowicz M; Szamatowicz J
    Endokrinologie; 1967; 52(3):262-70. PubMed ID: 5591950
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of breast structure and oestrogen and pregnanediol excretion in mammary cancer patiens.
    JULL JW; DOSSETT PJ; SHUCKSMITH HS; BONSER GM
    Acta Unio Int Contra Cancrum; 1959; 15():1108-13. PubMed ID: 14408140
    [No Abstract]   [Full Text] [Related]  

  • 17. [Excretion of estrogens, pregnanediol and 17-ketosteroids in women using intrauterine contraceptives].
    Latyk IV
    Akush Ginekol (Mosk); 1971 Feb; 47(2):25-6. PubMed ID: 5118534
    [No Abstract]   [Full Text] [Related]  

  • 18. [The excretion of classical estrogens and total phenolsteroids in patients with uterine cancer].
    Bershteĭn LM
    Vopr Onkol; 1967; 13(9):48-52. PubMed ID: 5599604
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary steroid hormones in normal Japanese women and primary breast cancer patients.
    Murayama Y; Utsunomiya J; Asano K
    Nihon Gan Chiryo Gakkai Shi; 1978 Dec; 13(6):663-75. PubMed ID: 744884
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary hormone metabolite levels in patients with cancer of the breast, prostate and lung.
    Marmorston J
    Ann N Y Acad Sci; 1966 Jan; 125(3):959-73. PubMed ID: 5223416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.